XML 75 R40.htm IDEA: XBRL DOCUMENT v3.21.2
The Company - Additional Information (Detail)
$ in Thousands
3 Months Ended 12 Months Ended
Jul. 31, 2020
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Jun. 30, 2021
USD ($)
shares
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
BARDA income $ 1,600 $ 440 $ 570 $ 449 $ 596 $ 481 $ 1,008 $ 386 $ 2,051 $ 2,055 $ 3,926 $ 5,921
Description of stock exchange ratio                   As a result, the Company became the sole shareholder of AVITA Medical and the new parent company of the AVITA Group. In conjunction with the Redomiciliation, an implicit consolidation or reverse split on a 1 for 100 basis was implemented whereby shareholders of AVITA Medical received one share of common stock in the Company for every 100 shares held in AVITA Medical.    
Reverse stock split                   reverse split on a 1 for 100 basis    
Stock split conversion ratio                   100    
CHESS Depositary Interests                        
Stock split conversion ratio                   0.05    
Stockholders equity stock split                   five CDIs in the Company for every 100 ordinary shares in AVITA Medical that were held by them    
Numbers shares equivalent to one common share | shares                   5    
American Depositary Shares                        
Stock split conversion ratio                   5    
Stockholders equity stock split                   one share of common stock in the Company for every 5 ADSs in AVITA Medical that were held by them    
BARDA | RECELL system                        
Contract amount $ 7,600                      
Number of Units Delivered 5,614                 5,614